Ağır Metallerin Kemik Dokusu Üzerinde Klinik ve Biyokimyasal Etkileri

Said Altıkat

doi:10.37609/akya.3293

Yazarlar

Said Altıkat

https://orcid.org/0000-0002-5763-3787

DOI: https://doi.org/10.37609/akya.3293.c11485

Özet

Bu makale, çevresel faktörler ve sanayileşme sonucunda toprak, su ve havada biriken ağır metallerin kemik dokusu üzerindeki etkilerini inceliyor. Kurşun, cıva, kadmiyum, arsenik gibi toksik metallerin kemiklerde birikip yapısal ve fonksiyonel bozukluklara neden olduğu belirtiliyor. Bu metaller, kemik mineralizasyonunu bozarak, osteoporoz, osteomalazi gibi kemik hastalıklarına yol açmakta, kemik yapım (osteoblast) ve yıkım (osteoklast) hücrelerinin işleyişini olumsuz etkileyerek kemik dokusunun dengesini bozmaktadır.
Makale, ağır metallerin özellikle sanayi devrimi sonrası artan çevresel kirlenme ile birlikte daha fazla yaygınlaştığını ve bu durumun insan sağlığı üzerindeki olumsuz etkilerini vurguluyor. Kemiklerde biriken bu metallerin, kalsiyum ve fosfor gibi önemli minerallerin yerini alarak kemik dayanıklılığını azalttığı, kemik deformasyonlarına ve zayıflamış kemik yapısına yol açtığı tespit edilmiştir. Ayrıca, kemik dokusunda meydana gelen bu bozulmaların uzun vadeli etkileri arasında ciddi kemik hastalıkları ve patolojik durumlar yer almaktadır. Çalışma, ağır metal kirliliğinin küresel bir sağlık sorunu olarak ele alınması gerektiğini vurgulamakta ve bu metallerin canlı organizmalar üzerindeki geniş kapsamlı etkilerini incelemektedir.

This article examines the effects of heavy metals accumulated in soil, water and air as a result of environmental factors and industrialisation on bone tissue. It is stated that toxic metals such as lead, mercury, cadmium and arsenic accumulate in bones and cause structural and functional disorders. These metals cause bone diseases such as osteoporosis and osteomalacia by disrupting bone mineralisation, and disrupt the balance of bone tissue by negatively affecting the functioning of bone building (osteoblast) and destruction (osteoclast) cells.
The article emphasises that heavy metals have become more widespread with increasing environmental pollution, especially after the industrial revolution, and the negative effects of this situation on human health. These metals accumulated in bones have been found to reduce bone strength by replacing important minerals such as calcium and phosphorus, leading to bone deformations and weakened bone structure. In addition, the long-term effects of these deteriorations in bone tissue include serious bone diseases and pathological conditions. The study emphasises that heavy metal pollution should be addressed as a global health problem and examines the wide-ranging effects of these metals on living organisms.

Referanslar

Rusyniak D.E., Arroyo A., Acciani J., et al. Heavy metal poisoning: Management of intoxication and antidotes. Exs. 2010;100:365–396. doi: 10.1007/978-3-7643-8338-1_11.

Ibrahim D., Froberg B., Wolf A. et al.,. Heavy metal poisoning: Clinical presentations and pathophysiology. Clin. Lab. Med. 2006;26:67–97. doi: 10.1016/j.cll.2006.02.003.

Wiley J.F., II Difficult diagnoses in toxicology: Poisons not detected by the comprehensive drug screen. Pediatr. Clin. N. Am. 1991;38:725–737. doi: 10.1016/S0031-3955(16)38127-5.

Desenclos J.C., Wilder M.H., Coppenger G.W., et al. Thallium poisoning: An outbreak in Florida, 1988. South Med. J. 1992;85:1203–1206. doi: 10.1097/00007611-199212000-00012.

Peter A.L., Viraraghavan T. Thallium: A review of public health and environmental concerns. Environ.Int. 2005;31:493–501. doi:10.1016/j.envint. 2004. 09.003.

Sharquie K.E., Ibrahim G.A., Noaimi A.A. et al. Outbreak of thallium poisoning among Iraqi patients. J. Saudi Soc. Dermatol. Dermatol. Surg. 2011;15:29–32. doi: 10.1016/j.jssdds.2010.10.006

Garg V. K., Yadav P., Mor S., et al. Heavy metals bioconcentration from soil to vegetables and assessment of health risk caused by their ingestion. Biological Trace Element Research. 2014;157(3):256–265. doi:10.1007/s12011-014-9892-z.

Priest N. D. The biological behaviour and bioavailability of aluminium in man, with special reference to studies employing aluminium-26 as a tracer: Review and study update. Journal of Environmental Monitoring. 2004;6(5):375–403. doi: 10.1039/b314329p.

Soni M. G., White S. M., Flamm W. G., et al. Safety evaluation of dietary aluminum. Regulatory Toxicology and Pharmacology. 2001;33(1):66–79. doi: 10.1006/rtph.2000.1441

Boran A. M., Al-Khatib A. J., Alanazi B. S et al. Investigation of aluminum toxicity among workers in aluminum industry sector. European Scientific Journal. 2019; 9:24.

Gupta N., Gaurav S. S., Kumar A. Molecular basis of aluminium toxicity in plants: a review. American Journal of Plant Sciences. 2013;4(12):21–37. doi: 10.4236/ajps.2013.412a3004.

Herndon J. M. Aluminum poisoning of humanity and Earth’s biota by clandestine geoengineering activity: implications for India. Current Science. 2015;108(12):2173–2177.

Lavoie A. R., Dubin V., Plombon J., et al. Selective aluminum doping of copper interconnects and structures formed thereby. 2008. Google Patents.

Ng C., Yahaya S., Majid A. Reviews on aluminum alloy series and its applications. Academia Journal of Scientific Research. 2017;5(12):708–716.

Skejić D., Boko I., Torić N. Aluminium as a material for modern structures. Građevinar. 2016;11:1075–1085.

Gándara M. F. Aluminium: the metal of choice. Mater Tehnol. 2013;47(3):261–265.

Grund, Sabina C., Hanusch, et al. "Arsenic and Arsenic Compounds". Ullmann's Encyclopedia of Industrial Chemistry. Weinheim: Wiley-VCH. Doi: 10.1002/14356007.a03_113.pub2. ISBN 978-3527306732.

Anke M. (1986) "Arsenic", pp. 347–372 in Mertz W. (ed.), Trace elements in human and Animal Nutrition, 5th ed. Orlando, FL: Academic Press

Uthus EO (1992). "Evidency for arsenical essentiality". Environmental Geochemistry and Health. 14 (2): 55–58. Bibcode:1992EnvGH.14...55U. doi:10.1007/BF01783629.

Dibyendu S, Datta R (2007). "Biogeochemistry of Arsenic in Contaminated Soils of Superfund Sites". EPA. United States Environmental Protection Agency. Retrieved 25 February 2018.

Carelton J (2007). "Final Report: Biogeochemistry of Arsenic in Contaminated Soils of Superfund Sites". United States Environmental Protection Agency. Archived from the original on 28 July 2018. Retrieved 25 February 2018.

Fowler B. A., Chou C. H. S. J., Jones D R. L., et al. Handbook on the Toxicology of Metals. 4th. Chapter 28. Vol. 28. Academic Press; 2014.

Onishi H. Arsenic. In: Wedepohl K.H., editor. Handbook of Geochemistry. Volume II Springer; New York, NY, USA: 1969.

Hughes M.F., Beck B.D., Chen Y., et al. Arsenic exposure and toxicology: A historical perspective. Toxicol. Sci. 2011;123:305–332.doi: 10.1093/toxsci/kfr184

Singh R., Singh S., Parihar P., et al. Arsenic contamination, consequences and remediation techniques: A review. Ecotoxicol. Environ. Saf. 2015;112:247–270. doi: 10.1016/j.ecoenv.2014.10.009

Ravenscroft P., Brammer H., Richards K. Arsenic Pollution A Global Synthesis. Wiley-Blackwell; Oxford, UK: 2009.

Mochizuki H., Phyu K.P., Aung M.N., et al. Peripheral neuropathy induced by drinking water contaminated with low-dose arsenic in Myanmar. Environ. Health Prev. Med. 2019;24:23. doi: 10.1186/s12199-019-0781-0

https://www.mta.gov.tr/v3.0/metalik-madenler/bakir

Doebrich J.L. Copper: A Metal for the Ages. US Department of the Interior, US Geological Survey; Liston, VA, USA: 2009

Gamakaranage C.S., Rodrigo C., Weerasinghe S., et al. Complications and management of acute copper sulphate poisoning; a case discussion. J. Occup. Med. Toxicol. 2011; 6:34. doi: 10.1186/1745-6673-6-34

Peña M.M., Lee J., Thiele D.J. A delicate balance: Homeostatic control of copper uptake and distribution. J. Nutr. 1999; 129:1251–1260. doi: 10.1093/jn/ 129.7.1251.

Rotilio G., Carr M., Rossi L et al.. Copper-dependent oxidative stress and neuro degeneration. IUBMB Life. 2000;50:309–314. doi: 10.1080/15216540051081074

Gu M., Cooper J., Butler P., et al. Oxidative-phosphorylation defects in liver of patients with Wilson’s disease. Lancet. 2000; 356:469–474. doi:10.1016/S0140 6736(00)02556-3.

Peter A. Mayes Robert K. Murray. Harper's Biochemistry 25.edition McGraw-Hill Publishing Co; 25th edition (January 1, 1999) pp;106-107

Berlin M., Zalups R. K., Fowler B. A. Mercury, in Handbook on the Toxicology of Metals. 3rd. chapter 33. Nordberg G. F., Fowler A. B., Nordberg M., et al. editors. New York, NY, USA: Elsevier; 2007.

Syversen T., Kaur P. The toxicology of mercury and its compounds. Journal of Trace Elements in Medicine and Biology. 2012;26(4):215–226. doi: 10.1016/j.jtemb.2012.02.004.

Mahaffey K. R., Clickner R. P., Bodurow C. C. Blood organic mercury and dietary mercury intake: National Health and Nutrition Examination Survey, 1999 and 2000. Environmental Health Perspectives.2004;112(5):562–570. doi:10.1289/ehp.6587.

Bernhoft R. A. Mercury toxicity and treatment: a review of the literature. Journal of Environmental and Public Health. 2012; 2012:10. doi:10.1155/2012/460508.460508.

Maqbool F., Niaz K., Hassan F. I., et al. Immunotoxicity of mercury: Pathological and toxicological effects. Journal of Environmental Science and Health- Part C Environmental Carcinogenesis and Ecotoxicology Reviews. 2017;35(1):29–46. doi: 10.1080/10590501.2016.1278299.

Rice K. M., Walker E. M., Jr., et al. Environmental mercury and its toxic effects. Journal of Preventive Medicine & Public Health. 2014;47(2):74–83. doi: 10.3961/jpmph.2014.47.2.74.

Nordberg G., Fowler B., Nordbergt M. Handbook on the Toxicology of Metals. 4th. Vol. 61. Academic Press; 2014

Trakulsrichai S., Kosanyawat N., Atiksawedparit P., et al. Clinical characteristics of zinc phosphide poisoning in Thailand. Therapeutics and Clinical Risk Management. 2017; 13:335–340. doi: 10.2147/TCRM.S129610

El Idrissi A., van Berkel L., Bonekamp N. E., et al. The toxicology of zinc chloride smoke producing bombs and screens. Clinical Toxicology. 2017;55(3):167–174. doi: 10.1080/15563650.2016.1271125.

Abhilash K.P., Arul J.J., Bala D. Fatal overdose of iron tablets in adults. Indian J. Crit. Care Med. 2013; 17:311–313. doi: 10.4103/0972-5229.120326.]

Mackenzie E.L., Iwasaki K., Tsuji Y. Comprehensive Invited Review. Antioxid. Redox Signal. 2008;10

Gerlach M., Ben-Shachar D., Riederer P., et al. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 1994; 63:793–807. doi: 10.1046/j.1471-4159.1994.63030793.x.

Jia P., Xu Y. J., Zhang Z. L., et al. Ferric ion could facilitate osteoclast differentiation and bone resorption through the production of reactive oxygen species. Journal of Orthopaedic Research. 2012;30(11):1843–1852. doi: 10.1002 /jor.22133.

Guggenbuhl P., Brissot P., Loréal O. Haemochromatosis: The bone and the joint. Best Practice & Research Clinical Rheumatology. 2011;25(5):649–664. doi: 10.1016/j.berh.2011.10.014.

Leung A. O. W., Duzgoren-Aydin N. S., Cheung K. C., Wong M. H. Heavy metals concentrations of surface dust from e-waste recycling and its human health implications in southeast China. Environmental Science & Technology. 2008;42(7):2674–2680. doi: 10.1021/es071873x.

Guo Y., Huo X., Li Y., et al. Monitoring of lead, cadmium, chromium and nickel in placenta from an e-waste recycling town in China. Science of the Total Environment. 2010;408(16):3113–3117. doi: 10.1016/j.scitotenv.2010.04.018

Weidenhamer J. D., Miller J., Guinn D., Pearson J. Bioavailability of cadmium in inexpensive jewelry. Environmental Health Perspectives. 2011;119(7):1029–1033. doi: 10.1289/ehp.1003011

Järup L., Åkesson A. Current status of cadmium as an environmental health problem. Toxicology and Applied Pharmacology. 2009;238(3):201–208. doi: 10.1016/j.taap.2009.04.020.

Nogawa K. Kanazawa Medical University Uchinada, Ishikawa, Japan; Proceedings of the Changing Metal Cycles and Human Health: Report of the Dahlem Workshop on Changing Metal Cycles and Human Health; Berlin, Germany. 20–25 March 1983; Berlin/Heidelberg, Germany: Springer; p. 275.

Probst G. Cadmium: Absorption and excretion in mammals. In: Mennear J.H., editor. Cadmium Toxicity. Marcel Dekker, Inc.; New York, NY, USA: 1979. pp. 29–59.

Świergosz R., Zakrzewska M., Sawicka-Kapusta K et al. Accumulation of cadmium in and its effect on bank vole tissues after chronic exposure. Ecotoxicol. Environ. Saf. 1998; 41:130–136. doi: 10.1006/eesa.1998.1677

Järup L. Hazards of heavy metal contamination. Br. Med. Bull. 2003; 68:167–182. doi: 10.1093/bmb/ldg032.

Godt J., Scheidig F., Grosse-Siestrup C., et al. The toxicity of cadmium and resulting hazards for human health. J. Occup. Med. Toxicol. 2006; 1:22. doi: 10.1186/1745-6673-1-22.

Johri N., Jacquillet G., Unwin R. Heavy metal poisoning: The effects of cadmium on the kidney. Biometals. 2010; 23:783–792. doi: 10.1007/s10534-010-9328-y.

Järup L., Berglund M., Elinder C.G., et al. Health effects of cadmium exposure–a review of the literature and a risk estimate. Scand. J. Work. Environ. Health. 1998; 24:1–51

Hogervost J., Plusquin M., Vangronsvel J., et al. House dust as possible route of environmental exposure to cadmium and lead in the adult general population. Environ. Res. 2007; 103:30–37. doi: 10.1016/j.envres.2006.05.009.

Casado M., Anawar H.M., Garcia-Sanchez A., et al. Cadmium and zinc in polluted mining soils and uptake by plants (El Losar mine, Spain) Int. Environ. Pollut. 2008; 33:146–159. doi: 10.1504/IJEP.2008.019389.

World Health Organization. OMS- IPCS. Concise International Chemical Assessment 78. Inorganic Chromium (VI) Compounds. http://www.who.int/ipcs/ publications/cicad/cicad 78.pdf?ua=1, 2013.

Agency for Toxic Substances and Disease Registry (ATSDR) Toxicological Profile for Chromium. Atlanta, GA, USA: Department of Health and Human Services, Public Health Service; 212.

Remy L. L., Byers V., Clay T. Reproductive outcomes after non-occupational exposure to hexavalent chromium, Willits California, 1983-2014. Environmental Health. 2017;16(1) doi: 10.1186/s12940-017-0222-8.

Sun H., Brocato J., Costa M. Oral Chromium Exposure and Toxicity. Current Environmental Health Reports. 2015;2(3):295–303. doi: 10.1007/s40572-015-0054-z.

Shah KM, Quinn PD, Gartland A, et al. Understanding the tissue effects of tribo-corrosion: uptake, distribution, and speciation of cobalt and chromium in human bone cells. J Orthop Res. 2015 Jan;33(1):114-21. doi: 10.1002/jor.22729. Epub 2014 Sep 23. PMID: 25251692.

Assi M. A., Hezmee M. N. M., Haron A. W., et al. The detrimental effects of lead on human and animal health. Veterinary World. 2016;9(6):660–671. doi: 10.14202/vetworld.2016.660-671

Järup L. Hazards of heavy metal contamination. British Medical Bulletin. 2003;68(1):167–182. doi: 10.1093/bmb/ldg032.

Klein C., Costa M. Handbook on the Toxicology of Metals. 3th. Academic Press; 2007.

Duda-Chodak A., Błaszczyk U. The impact of nickel on human health. Journal of Elementology. 2008;13(4):685–696.

Taiyi J., Berlin M. Handbook on the Toxicology of Metals. 4th. Chapter 57. Academic Press; 2014.

Shea J. E., Miller S. C. Skeletal function and structure: implications for tissue-targeted therapeutics. Advanced Drug Delivery Reviews. 2005;57(7):945–957. doi: 10.1016/j.addr.2004.12.017.

Choi JY. Healthy bone tissue homeostasis. Exp Mol Med. 2020 Aug;52(8):1165. doi: 10.1038/s12276-020-0472-3. Epub 2020 Aug 13. PMID: 32788654;

Farr JN, Khosla S. Cellular senescence in bone. Bone. 2019 Apr; 121:121-133. doi: 10.1016/j.bone.2019.01.015. Epub 2019 Jan 16.

Lee JY, Taub PJ, Wang L, et al. Identification of CITED2 as a negative regulator of fracture healing. Biochem Biophys Res Commun. 2009 Oct 2;387(4):641-5. doi: 10.1016/j.bbrc.2009.07.029. Epub 2009 Jul 14.

Calvo-Gallego JL, Manchado-Morales P, Pivonka P, Martínez-Reina J. Spatio-temporal simulations of bone remodelling using a bone cell population model based on cell availability. Front Bioeng Biotechnol. 2023 Mar 7; 11:1060158. doi: 10.3389/fbioe.2023.1060158.

Cohn, D. V. & Forscher, B. K. Aerobic metabolism of glucose by bone. J. Biological Chem. 237, 615–618 (1962).

Peck, W. A., Birge, S. J. Jr., Fedak, S. A. Bone cells: biochemical and biological studies after enzymatic isolation. Science 146, 1476–1477 (1964).

Misra, B. B., Jayapalan, S., Richards, A. K., et al. Untargeted metabolomics in primary murine bone marrow stromal cells reveals distinct profile throughout osteoblast differentiation. Metabolomics 17, 86 (2021).

Komarova, S. V., Ataullakhanov, F. I., Globus, R. K. Bioenergetics and mitochondrial transmembrane potential during differentiation of cultured osteoblasts. Am. J. Physiol. Cell Physiol. 279, C1220–1229 (2000).

Passi-Even, L., Gazit, D., Bab, I. Ontogenesis of ultrastructural features during osteogenic differentiation in diffusion chamber cultures of marrow cells. J. Bone Min. Res. 8, 589–595 (1993).

Pino, A. M., Miranda, M., Figueroa, C., et al. Qualitative Aspects of Bone Marrow Adiposity in Osteoporosis. Front. Endocrinol. 7, 139 (2016).

Brown, A. L. Jr., Taylor, W. F., Carter, R. E. The reliability of measures of amphibole fiber concentration in water. Environ. Res. 12, 150–160 (1976).

Jensen, V. F. H., Molck, A. M., Dalgaard, M., et al. Changes in bone mass associated with obesity and weight loss in humans: Applicability of animal models. Bone 145, 115781 (2021).

Taubmann, J. et al. Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis. Sci. Rep. 10, 21020 (2020).

Indo, Y. et al. Metabolic regulation of osteoclast differentiation and function. J. Bone Min. Res. 28, 2392–2399 (2013).

Park-Min, K. H. Metabolic reprogramming in osteoclasts. Semin. Immunopathol. 41, 565–572 (2019).

Lemma, S. et al. Energy metabolism in osteoclast formation and activity. Int. J. Biochem. Cell Biol. 79, 168–180 (2016).

Indo, Y. et al. Metabolic regulation of osteoclast differentiation and function. J. Bone Min. Res. 28, 2392–2399 (2013).

Bae, S. et al. MYC-dependent oxidative metabolism regulates osteoclastogenesis via nuclear receptor ERRalpha. J. Clin. Invest. 127, 2555–2568 (2017).

Yang, M. & Vousden, K. H. Serine and one-carbon metabolism in cancer. Nat. Rev. Cancer 16, 650–662 (2016).

Sato, T., Morita, I., Murota, S. Involvement of cholesterol in osteoclast-like cell formation via cellular fusion. Bone 23, 135–140 (1998).

Okayasu, M. et al. Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion. J. Biol. Chem. 287, 19229–19241 (2012).

Zhou, R. et al. Endocrine role of bone in the regulation of energy metabolism. Bone Res. 9, 25 (2021).95-

Moser, S. C. & van der Eerden, B. C. J. Osteocalcin-A Versatile Bone-Derived Hormone. Front. Endocrinol. 9, 794 (2018).97-

Karsenty, G. Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab. 4, 341–348 (2006).

Schneeweis LA, Willard D, Milla ME (December 2005). "Functional dissection of osteoprotegerin and its interaction with receptor activator of NF-kappaB ligand". The Journal of Biological Chemistry. 280 (50): 41155–64. doi:10.1074/jbc.M506366200.

Baud'huin M, Duplomb L, Teletchea S, (October 2013). "Osteoprotegerin: multiple partners for multiple functions”. Cytokine & Growth Factor Reviews. 24 (5): 401–9. doi: 10.1016/j.cytogfr.2013.06.001. PMID 23827649.

Simonet WS, Lacey DL, Dunstan CR, (April 1997). "Osteoprotegerin: a novel secreted protein involved in the regulation of bone density". Cell. 89 (2): 309–19. doi:10.1016/s1525-0016(16)39531-4. PMID 9108485.

Reid PE, Brown NJ, Holen I (July 2009). "Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact". Molecular Cancer. 8 (1): 49. doi:10.1186/1476-4598-8-49. PMC 2719583.

Yano K, Shibata O, Mizuno A, E (October 2001). "Immunological study on circulating murine osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF): possible role of OPG/OCIF in the prevention of osteoporosis in pregnancy". Biochemical and Biophysical Research Communications. 288 (1): 217–24. doi:10.1006/bbrc.2001.5745.

Fortner RT, Sarink D, Schock H, (February 2017). "Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort". BMC Medicine. 15 (1): 26. doi:10.1186/s12916-017-0786-8.

Schneeweis LA, Willard D, Milla ME (December 2005). "Functional dissection of osteoprotegerin and its interaction with receptor activator of NF-kappaB ligand". The Journal of Biological Chemistry. 280 (50): 41155–64. doi:10.1074/jbc.M506366200

Kobayashi Y, Thirukonda GJ, Nakamura Y, (August 2015). "Wnt16 regulates osteoclast differentiation in conjunction with Wnt5a". Biochemical and Biophysical Research Communications. 463 (4): 1278–83. doi: 10.1016/j. bbrc.2015.06.102.

Delgado-Calle J, Sañudo C, Fernández AF, (January 2012). "Role of DNA methylation in the regulation of the RANKL-OPG system in human bone". Epigenetics. 7 (1): 83–91. doi:10.4161/epi.7.1.18753.

Michael H, Härkönen PL, Väänänen HK (December 2005). "Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption". Journal of Bone and Mineral Research. 20 (12): 2224–32. doi:10.1359/JBMR.050803.

Millán MM (2015). "The Role of Estrogen Receptor in Bone Cells". Clinical Reviews in Bone and Mineral Metabolism. 13 (2): 105–112. doi:10.1007/s12018-015-9188-7. S2CID 195318812.

Jia J, Zhou H, Zeng X, (April 2017). "Estrogen stimulates osteoprotegerin expression via the suppression of miR-145 expression in MG-63 cells". Molecular Medicine Reports. 15 (4): 1539–1546. doi:10.3892/mmr.2017.6168. PMC 5364970. PMID 28260003.

Piperigkou Z, Franchi M, Götte M (December 2017). "Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer". Matrix Biology. 64: 94–111. doi: 10.1016/j.matbio.2017.08.002. PMID 28797712.

Li B., Wang P., Jiao J., et al. Roles of the RANKL–RANK Axis in Immunity—Implications for Pathogenesis and Treatment of Bone Metastasis. Front. Immunol. 2022; 13:824117. doi: 10.3389/fimmu.2022.824117.

Pfitzner B.M., Branstetter D., Loibl S., et al. RANK Expression as a Prognostic and Predictive Marker in Breast Cancer. Breast Cancer Res. Treat. 2014;145:307–315. doi: 10.1007/s10549-014-2955-1.

Lacey D.L., Timms E., Tan H., et al. Osteoprotegerin Ligand Is a Cytokine That Regulates Osteoclast Differentiation and Activation. Cell. 1998;93:165–176. doi: 10.1016/S0092-8674(00)81569-X.

D. D.L.Oliva, S.B.Blázquez,L.J.Álvarez, et al. The RANK–RANKL–OPG System: A Multifaceted Regulator of Homeostasis, Immunity, and Cancer2023 Sep30.doi:10.3390/medicina59101752 Medicina. 2023 Oct; 59(10): 1752.

Cao J.,Venton L.,Sakata T.,et al.Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice. Journal of Bone and Mineral Research. 2003;18(2):270–277. doi:10.1359/jbmr.2003.18.2 .270.

Boyce BF, Xing L (May 2008). "Functions of RANKL/RANK/OPG in bone modeling and remodeling". Archives of Biochemistry and Biophysics. 473 (2): 139–46. doi: 10.1016/j.abb.2008.03.018. PMC 2413418. PMID 18395508.

Boyle WJ, Simonet WS, Lacey DL (May 2003). "Osteoclast differentiation and activation". Nature. 423 (6937): 337–42. Bibcode:2003 Natur. 423..337B. doi:10.1038/nature01658.

Boyce BF, Xiu Y, Li J, (March 2015). "NF-κB-Mediated Regulation of Osteoclastogenesis". Endocrinology and Metabolism. 30 (1): 35–44. doi:10.3803/EnM.2015.30.1.35.

Kim JH, Kim N (November 2014). "Regulation of NFATc1 in Osteoclast Differentiation". Journal of Bone Metabolism. 21 (4): 233–41. doi:10.11005/jbm.2014.21.4.233.

Yen ML, Hsu PN, Liao HJ, (2012). "TRAF-6 dependent signaling pathway is essential for TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation". PLOS ONE. 7 (6): e38048. Bibcode:2012PLoSO...738048Y. doi: 10.1371/journal.pone.0038048.

Chamoux E, Houde N, L'Eriger K, (August 2008). "Osteoprotegerin decreases human osteoclast apoptosis by inhibiting the TRAIL pathway". Journal of Cellular Physiology. 216 (2): 536–42. doi:10.1002/jcp.21430.

Colucci S, Brunetti G, Cantatore FP, (September 2007). "The death receptor DR5 is involved in TRAIL-mediated human osteoclast apoptosis". Apoptosis. 12 (9): 1623–32. doi:10.1007/s10495-007-0095-3.

Vitovski S, Phillips JS, Sayers J, (October 2007). "Investigating the interaction between osteoprotegerin and receptor activator of NF-kappaB or tumor necrosis factor-related apoptosis-inducing ligand: evidence for a pivotal role for osteoprotegerin in regulating two distinct pathways". The Journal of Biological Chemistry. 282 (43): 31601–9. doi:10.1074/jbc.M706078200.

Gao Y, Chen N, Fu Z, et al. Progress of Wnt Signaling Pathway in Osteoporosis. Biomolecules. 2023 Mar 6;13(3):483. doi: 10.3390/biom13030483.

De A. Wnt/Ca2+ signaling pathway: a brief overview. Acta Biochim Biophys Sin (Shanghai). 2011 Oct;43(10):745-56. doi: 10.1093/abbs/gmr079. Epub 2011 Sep 7.

Maly I. P., Eppler E., Müller-Gerbl M. High metabolic activity of tissue-nonspecific alkaline phosphatase not only in young but also in adult bone as demonstrated using a new histochemical detection protocol. General and Comparative Endocrinology.2018;258:109.118.doi:10.1016/j.ygcen.2017.05.008

Chappard D., Mabilleau G., Moukoko D., et al. Aluminum and iron can be deposited in the calcified matrix of bone exostoses. Journal of Inorganic Biochemistry. 2015;152:174–179. doi: 10.1016/j.jinorgbio.2015.09.008.

Yang X., Huo H., Xiu C., et al. Inhibition of osteoblast differentiation by aluminum trichloride exposure is associated with inhibition of BMP-2/Smad pathway component expression. Food and Chemical Toxicology. 2016;97:120–126. doi: 10.1016/j.fct.2016.09.004.

Song M., Huo H., Cao Z., et al. Aluminum trichloride inhibits the rat osteoblasts mineralization in vitro. Biological Trace Element Research. 2017;175(1):186–193. doi: 10.1007/s12011-016-0761-9.

Degeratu C. N., Mabilleau G., Cincu C., Chappard D. Aluminum inhibits the growth of hydroxyapatite crystals developed on a biomimetic methacrylic polymer. Journal of Trace Elements in Medicine and Biology. 2013;27(4):346–351. doi: 10.1016/j.jtemb.2013.05.004.

Li X., Hu C., Zhu Y., et al. Effects of aluminum exposure on bone mineral density, mineral, and trace elements in rats. Biological Trace Element Research. 2011;143(1):378–385. doi: 10.1007/s12011-010-8861-4.

Sun X., Wang H., Huang W., et al. Inhibition of bone formation in rats by aluminum exposure via Wnt/Β-catenin pathway. Chemosphere. 2017;176:1–7. doi: 10.1016/j.chemosphere.2017.02.086.

Zhang F., Sun X., Yu H., et al. Effects of aluminum trichloride on the cartilage stimulatory growth factors in rats. BioMetals. 2017;30(1):143–150. doi: 10.1007/s10534-016-9982-9.

Aaseth J., Boivin G., Andersen O. Osteoporosis and trace elements.An overview. Journal of Trace Elements in Medicine and Biology. 2012;26(2-3):149–152. doi: 10.1016/j.jtemb.2012.03.017.

Chappard D., Bizot P., Mabilleau G., et al. Aluminum and bone: Review of new clinical circumstances associated with Al3+ deposition in the calcified matrix of bone. Morphologie. 2016;100(329):95.105. doi:10.1016/j.morpho.2015.12.001

Nebeker H. G., Coburn J. W. Aluminum and renal osteodystrophy. Annual Review of Medicine. 1986; 37:79–95. doi:10.1146/annurev.me.37.020186.000455

Stahl T., Falk S., Rohrbeck A., et al. Migration of aluminum from food contact materials to food a health risk for consumers? Part I of III: exposure to aluminum, release of aluminum, tolerable weekly intake (TWI), toxicological effects of aluminum, study design, and methods. Environmental Sciences Europe. 2017;29(1)

Bhattacharya S. Medicinal plants and natural products in amelioration of arsenic toxicity: A short review. Pharmaceutical Biology. 2017;55(1):349–354. doi: 10.1080/13880209.2016.1235207.

Liu Z, Hou Y, Li L. Nrf2 deficiency aggravates the increase in osteoclastogenesis and bone loss induced by inorganic arsenic. Toxicol Appl Pharmacol. 2019 Mar 15; 367:62-70. doi: 10.1016/j.taap.2019.02.003. Epub 2019 Feb 8. Erratum in: Toxicol Appl Pharmacol. 2022 Jan 15; 435:115801. doi: 10.1016/j.taap.2021.115801.

Dani S. U. Osteoresorptive arsenic intoxication. Bone. 2013;53(2):541–545. doi: 10.1016/j.bone.2013.01.017.

Lever J. H. Paget's disease of bone in Lancashire and arsenic pesticide in cotton mill wastewater: A speculative hypothesis. Bone. 2002;31(3):434–436. doi: 10.1016/S8756-3282(02)00833-5

Chen G., Sung P.-T. Gingival and localized alveolar bone necrosisrelated to the use of arsenic trioxidepaste-Two case reports. Journal of the Formosan Medical Association. 2014;113(3):187–190. doi: 10.1016/j.jfma.2012.07.023.

Hu Y.-C., Cheng H.-L., Hsieh B.-S., et al. Arsenic trioxide affects bone remodeling by effects on osteoblast differentiation and function. Bone. 2012;50(6):1406–1415. doi: 10.1016/j.bone.2012.03.012

Chiu P. R., Hu Y. C., Hsieh B. S., et al. Osteoblasts active the Nrf2 signalling pathway in response to arsenic trioxide treatment. International Journal of Biochemistry & Cell Biology. 2016;79:327–336.

C.T. Wu, T.Y. Lu, D.C. Chan, Effects of arsenic on osteoblast differentiation in vitro and on bone mineral density and microstructure in rats Environ. Health Perspect., 122 (2014), pp. 559-565

K.H. Szymczyk, B.A. Kerr, T.A. Freeman, Involvement of hydrogen peroxide in the differentiation and apoptosis of preosteoclastic cells exposed to arsenite Biochem. Pharmacol., 72 (2006), pp. 761-769

C. Bohm, S. Hayer, A. Kilian, et al. The alpha-isoform of p38 MAPK specifically regulates arthritic bone loss J. Immunol. (Baltimore, MD: 1950), 183 (2009), pp. 5938-5947

L. Chang, M. Karin Mammalian MAP kinase signalling cascades Nature, 410 (2001), pp. 37-40

N.K. Lee, Y.G. Choi, J.Y. Baik, et al. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation Blood, 106 (2005), pp. 852-859

Q. Ma. Role of nrf2 in oxidative stress and toxicity Annu. Rev. Pharmacol.Toxicol.,53(2013), pp.401-426

J. Pi, B.A. Diwan, Y. Sun, et al. Arsenic-induced malignant transformation of human keratinocytes: involvement of Nrf2 Free Radic. Biol. Med., 45 (2008), pp. 651-658.

H. Kanzaki, F. Shinohara, M. Kajiya, et al. Nuclear Nrf2 induction by protein transduction attenuates osteoclastogenesis Free Radic. Biol. Med., 77 (2014), pp. 239-248

Agency for Toxic Substances and Disease Registry (ATSDR) Toxicological Profile for Copper. Atlanta, GA, USA: Department of Health and Human Services, Public Health Service; 2004.

Fuentealba I.C., Aburto E.M. Animal models of copper-associated liver disease. Comp. Hepatol. 2003; 2:5. doi: 10.1186/1476-5926-2-5

Chowdhury A., Ghosh S., Pal D. Acute copper sulphate poisoning. J. Indian Med. Assoc.1961;36:330–336.

Nastoulis E., Karakasi M., Couvaris C., et al. Greenish-blue gastric content: Literature review and case report on acute copper sulphate poisoning. Forensic Sci. Rev. 2017; 29:77–91.

Cozma I., Atherley C., James N. Influence of ethnic origin on the incidence of keratoconus and associated atopic disease in Asian and white patients. Eye. 2005; 19:924–925. doi: 10.1038/sj.eye.6701677.

Hsieh Y.-C., Tsai Y.-Y. Sunflower cataract. Postgrad. Med. J. 2016;92:366. doi: 10.1136/postgradmedj-2015-133929.

Suzuki N., Yamamoto M., Watanabe K., et al. Both mercury and cadmium directly influence calcium homeostasis resulting from the suppression of scale bone cells: The scale is a good model for the evaluation of heavy metals in bone metabolism. Journal of Bone and Mineral Metabolism. 2004;22(5):439–446. doi: 10.1007/s00774-004-0505-3

Yachiguchi K., Sekiguchi T., Nakano M., et al. Effects of inorganic mercury and methylmercury on osteoclasts and osteoblasts in the scales of the marine teleost as a model system of bone. Zoological Science. 2014;31(5):330–337. doi: 10.2108/zs130265.

Abd El-Aziz G. S., El-Fark M. M. O., Saleh H. A. M. The prenatal toxic effect of methylmercury on the development of the appendicular skeleton of rat fetuses and the protective role of vitamin E. Anatomical Record. 2012;295(6):939–949. doi: 10.1002/ar.22485.

Yamaguchi M. Role of nutritional zinc in the prevention of osteoporosis. Mol. Cell. Biochem. 2010;338: 241–254. doi: 10.1007/s11010-009-0358-0.

Haumont S. Distribution of zinc in bone tissue. J. Histochem. Cytochem. Off. J. Histochem. Soc. 1961;9:141–145. doi: 10.1177/9.2.141

Lappalainen R., Knuuttila M., Lammi S., et al. Fluoride content related to the elemental composition, mineral density and strength of bone in healthy and chronically diseased persons. J. Chronic Dis. 1983;36:707–713. doi: 10.1016/0021-9681(83)90164-9.

Jones D.C., Wein M.N., Oukka M., Hofstaetter J.G., Glimcher M.J., Glimcher L.H. Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3. Science. 2006;312:1223–1227. doi: 10.1126/science.1126313.

Levaot N., Hershfinkel M. How cellular Zn2+ signaling drives physiological functions. Cell Calcium. 2018;75:53–63. doi: 10.1016/j.ceca.2018.08.004

Shu C.C., Jackson M.T., Smith M.M et al. Ablation of Perlecan Domain 1 Heparan Sulfate Reduces Progressive Cartilage Degradation, Synovitis, and Osteophyte Size in a Preclinical Model of Posttraumatic Osteoarthritis. Arthritis Rheumatol. 2016;68:868–879. doi: 10.1002/art.39529.

Kim J.H., Jeon J., Shin M., et al. Regulation of the catabolic cascade in osteoarthritis by the zinc-ZIP8-MTF1 axis. Cell. 2014;156:730–743. doi: 10.1016/j.cell.2014.01.007.

Baranwal A.K.,Singhi S.C. Acute iron poisoning: Management guidelines.Indian Pediatr.2003;40:534.540

Sane M.R., Malukani K., Kulkarni R., et al.Fatal Iron Toxicity in an Adult: Clinical Profile and Review. Indian J. Crit. Care Med. 2018;22:801–803. doi: 10.4103/ijccm.IJCCM_188_18.

Lacoste H., Goyert G.L., Goldman L.S., et al. Acute iron intoxication in pregnancy: Case report and review of the literature. Obstet. Gynecol. 1992;80:500–501. doi: 10.1016/0020-7292(93)90211-E. [

Wang W.C., Ahmed N., Hanna M. Non-transferrin-bound iron in long-term transfusion in children with congenital anemias. J. Pediatr. 1986;108:552–557. doi: 10.1016/S0022-3476(86)80832-0.

Simonse E., Valk-Swinkels C.G., van ‘t Veer N.E., et al. Iron autointoxication in a 16-year-old girl: A protective role for hepcidin? Ann. Clin. Biochem. 2013;50:76–79. doi: 10.1258/acb.2012.012038.

Mahesh K., Rani R. A case of iron poisoning-case report. Int. J. Basic Appl. Med. Sci. 2014;4:101–103.

Robertson A., Tenenbein M. Hepatotoxicity in acute iron poisoning. Hum. Exp. Toxicol. 2005;24:559–562. doi: 10.1191/0960327105ht564oa

Gandhi R.K., Robarts F.H. Hour-glass stricture of the stomach and pyloric stenosis due to ferrous sulphate poisoning. Br. J. Surg. 1962;49:613–617. doi: 10.1002/bjs.18004921811.

Ekanayake D., Roddick C., Powell L.W. Recent advances in hemochromatosis: A 2015 update: A summary of proceedings of the 2014 conference held under the auspices of Hemochromatosis Australia. Hepatol. Int. 2015;9:174–182. doi: 10.1007/s12072-015-9608-2

Pietrangelo A. Hereditary hemochromatosis--a new look at an old disease. N. Engl. J. Med. 2004;350:2383–2397. doi: 10.1056/NEJMra031573.

Valenti L., Varenna M., Fracanzani A. L., et al. Association between iron overload and osteoporosis in patients with hereditary hemochromatosis. Osteoporosis International. 2009;20(4):549–555. doi: 10.1007/s00198-008-07014.

Marcucci G., Brandi M. L. Rare causes of osteoporosis. Clinical Cases in Mineral and Bone Metabolism. 2015;12(2):151–156.

Wang X., Chen B., Sun J., et al. Iron-induced oxidative stress stimulates osteoclast differentiation via NF-κB signaling pathway in mouse model. Metabolism- Clinical and Experimental. 2018;83:167–176. doi:10.1016/ j.metabol.2018.01.005.

Tsay J., Yang Z., Ross F. P., et al. Bone loss caused by iron overload in a murine model: Importance of oxidative stress. Blood. 2010;116(14):2582–2589. doi: 10.1182/blood-2009-12-260083.

Yuang Y., Xu F., Cao Y., et al. Iron accumulation leads to bone loss by inducing mesenchymal stem cells apoptosis through the activation of caspase 3. Biological Trace Element Research. 2018

Mandalunis P. M., Ubios A. M. Experimental renal failure and iron overload: a histomorphometric study in rat tibia. Toxicologic Pathology. 2005;33(3):398–403. doi: 10.1080/01926230590935826.

Isidori A., Borin L., Elli E., et al. Iron toxicity – Its effect on the bone marrow. Blood Reviews. 2018 doi: 10. 1016/j.blre.2018.04.004

He Y., Ma Y., Gao C., et al. Iron overload inhibits osteoblast biological activity through oxidative stress. Biological Trace Element Research. 2013;152(2):292–296. doi: 10.1007/s12011-013-9605-z.

Guggenbuhl P., Filmon R., Mabilleau G., et al. Iron inhibits hydroxyapatite crystal growth in vitro. Metabolism - Clinical and Experimental. 2008;57(7):903–910. doi: 10.1016/j.metabol.2008.02.004.

Jia P., Xu Y. J., Zhang Z. L., et al. Ferric ion could facilitate osteoclast differentiation and bone resoption through the production of reactive oxygen species. Journal of Orthopaedic Research Month. 2012:1–10.

Balogh E., Tolnai E., Nagy B., et al. Iron overload inhibits osteogenic commitment and differentiation of mesenchymal stem cells via the induction of ferritin. Biochimica et Biophysica Acta (BBA)- Molecular Basis of Disease. 2016; 1862(9):1640–1649. doi: 10.1016/j.bbadis.2016.06.003

Zhao G.Y., Zhao L.P., He Y.F., et al. A comparison of the biological activities of human osteoblast hFOB1.19 between iron excess and iron deficiency. Biological Trace Element Research. 2012;150(1-3):487–495. doi: 10.1007/s12011-012-9511-9

Messer J. G., Kilbarger A. K., Erikson K. M., et al. Iron overload alters iron-regulatory genes and proteins, down-regulates osteoblastic phenotype, and is associated with apoptosis in fetal rat calvaria cultures. Bone. 2009;45(5):972–979. doi: 10.1016/j.bone.2009.07.073.

WHO. Environmental Health Criteria. Volume 134 World Health Organization; Geneva, Switzerland: 1992. Cadmium.

Elinder C.G., Lind B., Kjellström T., Linnman L., Friberg L. Cadmium in kidney cortex, liver, and pancreas from Swedish autopsies. Estimation of biological half time in kidney cortex, considering calorie intake and smoking habits. Arch. Environ. Health. 1976;31:292–302. doi: 10.1080/00039896.1976. 1066 7239.

Zalups R.K., Ahmad S. Molecular handling of cadmium in transporting epithelia. Toxicol. Appl. Pharmacol. 2003; 186:163–188. doi: 10.1016/S0041-008 X (02)000 21-2.

Prabu S.M., Shagirtha K. Cadmium and Apoptosis: A Molecular Approach.Res. Rev.J. Toxicol. 2019; 6:8–17

Han Y.L., Sheng Z., Liu G.D., Long L.L., Wang Y.F., Yang W.X., Zhu J.Q. Cloning, characterization and cadmium inducibility of metallothionein in the testes of the mudskipper Boleophthalmus pectinirostris. Ecotoxicol. Environ. Saf. 2015; 119:1–8. doi: 10.1016/j.ecoenv.2015.04.055.

Satarug S. Dietary Cadmium intake and its effects on kidneys. Toxics.2018;6: 15.doi:10.3390/toxics.6010015

Tinkov A.A., Gritsenko V.A., Skalnaya M.G., Cherkasov S.V., Aaseth J., Skalny A.V. Gut as a target for cadmium toxicity. Environ. Pollut. 2018; 235:429–434. doi: 10.1016/j.envpol.2017.12.114

Tinkov A.A., Filippini T., Ajsuvakovae O.P., et al. Cadmium and atherosclerosis: A review of toxicological mechanisms and a meta-analysis of epidemiologic studies. Environ. Res. 2018; 162:240–260. doi: 10.1016/j.envres. 2018.01.008.

IARC (International Agency for Research on Cancer) Monographs on the Evaluation of the Carcinogenic Risks to Humans Beryllium, Cadmium, Mercury and Exposures in the Glass Manufacturing Industry. IARC Scientific Publications; Lyon, France: 1993. pp. 119–238.

IARC. Summary of Data Reported and Evaluation. Volume 58 International Agency for Cancer Research-World Health Organization; Geneva, Switzerland: 1997. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans-Beryllium, Cadmium, Mercury, and Exposures in the Glass Manufacturing Industry.

Mezynska M., Brzóska M.M. Environmental exposure to cadmium—A risk for health of the general population in industrialized countries and preventive strategies. Environ. Sci. Pollut. Res. 2018;25:3211–3232. doi: 10.1007/s11356-017-0827-z.

Buha A., Jugdaohsingh R., Matovic V., et al. Bone mineral health is sensitively related to environmental cadmium exposure-experimental and human data. Environ. Res. 2019;176:108539. doi: 10.1016/j.envres.2019.108539.

Bulmer F.M.R., Rothwel H.E., Frankish E.R. Industrial cadmium poisoning. Can. Public Health. 1938;29:19–26.

Hagino N., Yoshioka Y. A study of the etiology of Itai-Itai disease. J. Jpn. Orthop. Assoc. 1960;35:812–815.

Engström A., Michaëlsson K., Vahter M., et al.. Associations between dietary cadmium exposure and bone mineral density and risk of osteoporosis and fractures among women. Bone. 2012;50(6):1372–1378. doi: 10.1016/j.bone.2012.03.018.

Kazantzis G. Cadmium, osteoporosis and calcium metabolism. BioMetals. 2004;17(5):493–498. doi: 10.1023/B: BIOM.0000045727.76054.f3.

Åkesson A., Bjellerup P., Lundh T., et al. Cadmium-induced effects on bone in a population-based study of women. Environmental Health Perspectives. 2006; 114(6): 830–834. doi: 10.1289/ehp.8763.

Bernard A. Cadmium & its adverse effects on human health. Indian Journal of Medicine Research. 2008;128(4):557–564.

Yuan G., Dai S., Yin Z., et al. Toxicological assessment of combined lead and cadmium: Acute and sub-chronic toxicity study in rats. Food and Chemical Toxicology. 2014; 65:260–268. doi: 10.1016/j.fct.2013.12.041.

Kumar S., Sharma A. Cadmium toxicity: Effects on human reproduction and fertility. Rev. Environ. Health. 2019; 34:327–338. doi: 10.1515/reveh-2019-0016.

Kippler M., Ekström E.C., Lönnerdal B., et al. Influence of iron and zinc status on cadmium accumulation in Bangladeshi women. Toxicol. Appl. Pharmacol. 2007; 222:221–226. doi: 10.1016/j.taap.2007.04.009.

Reyes-Hinojosa D., Lozada-Pérez C.A., Zamudio Cuevas Y., et al. Toxicity of cadmium in musculoskeletal diseases. Environ. Toxicol. Pharmacol. 2019; 72:103219. doi: 10.1016/j.etap.2019.103219.

Brzóska M. M., Moniuszko-Jakoniuk J. Low-level exposure to cadmium during the lifetime increases the risk of osteoporosis and fractures of the lumbar spine in the elderly: Studies on a rat model of human environmental exposure. Toxicological Sciences. 2004;82(2):468–477. doi: 10.1093/toxsci/kfh275.

Wang Y., Fang J., Leonard S.S., et al. Cadmium inhibits the electron transfer chain and induces reactive oxygen species. Free Radic. Biol. Med. 2004; 36:1434–1443. doi: 10.1016/j.freeradbiomed.2004.03.010.

Brzóska M. M., Moniuszko-Jakoniuk J. Disorders in bone metabolism of female rats chronically exposed to cadmium. Toxicology and Applied Pharmacology. 2005;202(1):68–83. doi: 10.1016/j.taap.2004.06.007.

Chen X., Zhu G., Jin T., et al. Cadmium induces differentiation of RAW264.7 cells into osteoclasts in the presence of RANKL. Food and Chemical Toxicology. 2011;49(9):2392–2397. doi: 10.1016/j.fct.2011.06.053.

Chen X., Zhu G., Gu S., et al. Effects of cadmium on osteoblasts and osteoclasts in vitro. Environmental Toxicology and Pharmacology. 2009;28(2):232–236. doi: 10.1016/j.etap.2009.04.010.

Papa V., Bimonte V. M., Wannenes F., et al. The endocrine disruptor cadmium alters human osteoblast-like Saos-2 cells homeostasis in vitro by alteration of Wnt/β-catenin pathway and activation of caspases. Journal of Endocrinological Investigation. 2015;38(12):1345–1356. doi: 10.1007/s40618-015-0380-x.

Oliveira H., Monteiro C., Pinho F., et al. Cadmium-induced genotoxicity in human osteoblast-like cells. Mutation Research- Genetic Toxicology and Environmental Mutagenesis. 2014;775-776:38–47. doi: 10.1016/j.mrgentox.2014.10.002.

Hu K.-H., Li W.-X., Sun M.-Y., et al. Cadmium induced apoptosis in MG63 cells by increasing ROS, activation of p38 MAPK and inhibition of ERK 1/2 pathways. Cellular Physiology and Biochemistry. 2015;36(2):642–654. doi: 10.1159/000430127.

Keane Tahmaseb GC, Keane AM, Foppiani JA, Myckatyn TM. An Update on Implant-Associated Malignancies and Their Biocompatibility. Int J Mol Sci. 2024 A et al. pr 24;25(9):4653. doi: 10.3390/ijms25094653. PMID: 38731871;

Lee W.F., Wang J.C., Hsu C.Y., et al. Microstructure, mechanical properties, and retentive forces of cobalt-chromium removable partial denture frameworks fabricated by selective laser melting followed by heat treatment. J. Prosthet. Dent. 2022; 127:115–121. doi: 10.1016/j.prosdent.2020.06.038.

Sankaramanivel S., Jeyapriya R., Hemalatha D., et al. Effect of chromium on vertebrae, femur and calvaria of adult male rats. Human & Experimental Toxicology. 2006;25(6):311–318. doi: 10.1191/0960327105ht627oa.

De Lucca R. C., Dutrey P. L., Villarino M. E., et al. Effect of different doses of hexavalent chromium on mandibular growth and tooth eruption in juvenile Wistar rats. Experimental and Toxicologic Pathology. 2009;61(4):347–352. doi: 10.1016/j.etp.2008.10.001.

Andrews R. E., Shah K. M., Wilkinson J. M., Gartland A. Effects of cobalt and chromium ions at clinically equivalent concentrations after metal-on-metal hip replacement on human osteoblasts and osteoclasts: implications for skeletal health. Bone. 2011;49(4):717–723. doi: 10.1016/j.bone.2011.06.007.

Shah K. M., Wilkinson J. M., Gartland A. Cobalt and chromium exposure affects osteoblast function and impairs the mineralization of prosthesis surfaces in vitro. Journal of Orthopaedic Research. 2015;33(11):1663–1670. doi: 10.1002/jor.22932.

Shah K. M., Quinn P. D., Gartland A., et al. Understanding the tissue effects of tribo-corrosion: Uptake, distribution, and speciation of cobalt and chromium in human bone cells. Journal of Orthopaedic Research. 2015;33(1):114–121. doi: 10.1002/jor.22729.

Andrews RE, Shah KM, Wilkinson JM, et al. 2011. Effects of cobalt and chromium ions at clinically equivalent concentrations after metal-on-metal hip replacement on human osteoblasts and osteoclasts: implications for skeletal health. Bone 49: 717–723.

Prentice JR, Clark MJ, Hoggard N, et al. 2013. Metal-on-metal hip prostheses and systemic health: a cross-sectional association study 8 years after implantation. PloS One 8: e66186.

Gartland A, Hipskind RA, Gallagher JA, et al. 2001. Expression of a P2X7 receptor by a subpopulation of human osteoblasts. J Bone Miner Res 16: 846–856.

Gunshin H, Mackenzie B, Berger UV, et al. 1997. Cloning and characteri zation of a mammalian proton-coupled metal-ion transporter. Nature 388:482–488

Gray SJ, Sterling K. 1950. The tagging of red cells and plasma proteins with radioactive chromium. J Clin Invest 29: 1604–1613.

Tkaczyk C, Huk OL, Mwale F, et al. 2010. Investigation of the binding of Cr (III) complexes to bovine and human serum proteins: a proteomic approach. J Biomed Mater Res A 94: 214–222.

Muter E, Karl AN. Jacobson HK, et al. Chronic tubulointerstitial nephritis, Nephrology, 1995St Louis, MOMosby (pg. 220-1)

Kocak R, Anarat A, Altintas G, et al. Lead poisoning from contaminated flour in a family of 11 members, Human Toxicol, 1989, vol. 8 (pg. 385-6)

Nolan CV, Shaikh ZA. Lead nephrotoxicity and associated disorders: biochemical mechanisms, Toxicology, 1992, vol. 73 (pg. 127-46)

Popovic M, McNeill FE, Webber CE, et al. The effect of lead in bone densitometry, Nucl Instrum Methods Phys Res B, 2004, vol. 213 (pg. 599-602)

Rabinowitz MB. Toxicokinetics of bone lead, Environ Health Perspect, 1991, vol. 91 (pg. 33-7)

Franklin CA, Inskip MJ, Baccanale CL, et al. Use of sequentially administered stable lead isotopes to investigate changes in blood lead during pregnancy in a nonhuman primate (Macaca fascicularis), Fundam Appl Toxicol, 1997, vol. 39 (pg. 109-19)

Marika B, Agneta A, Per B, et al. Metal-bone interactions, Toxicol Lett, 2000, vol. 112–113 (pg. 219-25)

Silbergeld EK, Schwartz J, Mahaffey K. Lead and osteoporosis: mobilization of lead from bone in postmenopausal women, Environ Res, 1988, vol.47 (79-94)

Alfven T, Jarup L, Elinder C-G. Cadmium and lead in blood in relation to low bone mineral density and tubular proteinuria, Environ Health Perspect, 2002, vol. 110 (pg. 699-702)

Dongre N. N., Suryakar A. N., Patil A. J., et al. Biochemical effects of lead exposure on battery manufacture workers with reference to blood pressure, calcium metabolism and bone mineral density. Indian Journal of Clinical Biochemistry. 2013;28(1):65–70. doi: 10.1007/s12291-012-0241-8.

Skerfving S., Bergdahl I. Handbook on the Toxicology of Metals. 3th. Chapter 31 2007.

Flora G., Gupta D., Tiwari A. Toxicity of lead: a review with recent updates. Interdisciplinary Toxicology. 2012;5(2):47–58. doi: 10.2478/v10102-012-0009-2

Wong A. K., Beattie K. A., Bhargava A., et al. Bone lead (Pb) content at the tibia is associated with thinner distal tibia cortices and lower volumetric bone density in postmenopausal women. Bone. 2015; 79:58–64. doi: 10.1016/j.bone. 2015.05. 010.

Carmouche J. J., Puzas J. E., Zhang X., et al. Lead exposure inhibits fracture healing and is associated with increased chondrogenesis, delay in cartilage mineralization, and a decrease in osteoprogenitor frequency. Environmental Health Perspectives. 2005;113(6):749–755. doi: 10.1289/ehp.7596.

Shukla R., Bornschein R. L., Dietrich K. N., et al. Fetal and infant lead exposure: Effects on growth in stature. Pediatrics. 1989;84(4):604–612.

Monir A. U., Gundberg C. M., Yagerman S. E., et al. The effect of lead on bone mineral properties from female adult C57/BL6 mice. Bone. 2010;47(5):888–894. doi: 10.1016/j.bone.2010.07.013.

Beier E. E., Sheu T.-J., Dang D., et al. Heavy metal ion regulation of gene expression: Mechanisms by which lead inhibits osteoblastic bone-forming activity through modulation of the Wnt/β-catenin signaling pathway. The Journal of Biological Chemistry. 2015;290(29):18216.18226.doi:10.1074/jbc.M114.62920 4

Ma Y., Fu D., Liu Z. Effect of lead on apoptosis in cultured rat primary osteoblasts. Toxicology & Industrial Health. 2012;28(2):136–146. doi:10.1177/ 0748233711407956.

González-Riola J., Hernández E. R., Escribano A., et al. Effect of lead on bone and cartilage in sexually mature rats: A morphometric and histomorphometry study. Environmental Research. 1997;74(1):91–93. doi: 10.1006/enrs. 1997.37 60

Hicks D. G., O'Keefe R. J., Reynolds K. J., et al. Effects of lead on growth plate chondrocyte phenotype. Toxicology and Applied Pharmacology. 1996;140(1):164–172. doi: 10.1006/taap.1996.0209.

Morais S., Sousa J. P., Fernandes M. H. et al. In vitro biomineralization by osteoblast-like cells I. Retardation of tissue mineralization by metal salts. Biomaterials. 1998;19(1-3):13–21. doi: 10.1016/S0142-9612(97)00149-X.

Kanaji A., Orhue V., Caicedo M. S., et al. Cytotoxic effects of cobalt and nickel ions on osteocytes in vitro. Journal of Orthopaedic Surgery and Research. 2014;9(1, article no. 91) doi: 10.1186/s13018-014-0091-6.

C.H. Lohmann, Z. Schwartz, G. Koster, et al. Phagocytosis of wear debris by osteoblasts affects differentiation and local factor production in a manner dependent on particle compositionBiomaterials, 21 (6) (2000), pp. 551-561

N.J. Hallab, C. Vermes, C. Messina, et al. Concentration- and composition-dependent effects of metal ions on human MG-63 osteoblasts Journal of Biomedical Materials Research, 60 (3) (2002), pp. 420-433

J.Y. Wang, B.H. Wicklund, R.B. Gustilo, et al. Titanium, chromium and cobalt ions modulate the release of bone-associated cytokines by human monocytes/macrophages in vitro Biomaterials,17(23) (1996), pp.2233-2240

Kanaji A, Orhue V, Caicedo MS, et al. Cytotoxic effects of cobalt and nickel ions on osteocytes in vitro. J Orthop Surg Res. 2014 Oct 8; 9:91. doi: 10.1186/s13018-014-0091-6. PMID: 25288055; PMCID: PMC4194407.

Zhang X, Song Y, Gong H, et al. Neurotoxicity of Titanium Dioxide Nanoparticles: A Comprehensive Review. Int J Nanomedicine. 2023 Dec 5; 18:7183-7204. doi: 10.2147/IJN.S442801. PMID: 38076727;

Grande F, Tucci P. Titanium dioxide nanoparticles: a risk for human health? Mini Rev Med Chem. 2016;16(9):762–769. doi: 10.2174/1389557516666160321114341

Mueller NC, Nowack B. Exposure modeling of engineered nanoparticles in the environment. Environ Sci Technol. 2008;42(12):4447–4453. doi: 10.1021/es7029637

Shakeel M, Jabeen F, Shabbir S, et al. Toxicity of Nano-Titanium Dioxide (TiO2-NP) through various routes of exposure: a review. Biol Trace Elem Res. 2016;172(1):1–36. doi: 10.1007/s12011-015-0550-x

Ali SA, Rizk MZ, Hamed MA, et al. Assessment of titanium dioxide nanoparticles toxicity via oral exposure in mice: effect of dose and particle size. Biomarkers. 2019;24(5):492–498. doi: 10.1080/1354750X.2019.1620336

Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005 Jul;113(7):823-39. doi: 10.1289/ehp.7339. Erratum in: Environ Health Perspect. 2010 Sep;118(9): A380.

Grenón M. S., Robledo J., Ibáñez J. C., et al. Titanium diffusion in shinbone of rats with osseointegrated implants. Journal of Microscopy. 2016;264(2):182–188. doi: 10.1111/jmi.12428.

Wennerberg A., Ide-Ektessabi A., Hatkamata S., et al. Titanium release from implants prepared with different surface roughness: An in vitro and in vivo study. Clinical Oral Implants Research. 2004;15(5):505–512. doi: 10.1111/j.1600-0501.2004.01053.x.

Mine Y., Makihira S., Nikawa H., et al. Impact of titanium ions on osteoblast-, osteoclast- and gingival epithelial-like cells. Journal of Prosthodontic Research. 2010;54(1):1–6. doi: 10.1016/j.jpor.2009.07.003.

Zhu W.-Q., Ming P.-P., Qiu J., et al. Effect of titanium ions on the Hippo/YAP signaling pathway in regulating biological behaviors of MC3T3-E1 osteoblasts. Journal of Applied Toxicology. 2018; 38:824–833.

Liao H., Wurtz T., Li J. Influence of titanium ion on mineral formation and properties of osteoid nodules in rat calvaria cultures. Journal of Biomedical Materials Research Part B: Applied Biomaterials.1999;47(2):220.227. doi: 10.1002/(SICI)1097-4636(199911)47:2<220: AID-JBM12>3.0.CO;2-9.

Sun S. X., Guo H. H., Zhang J., et al. BMP-2 and titanium particles synergistically activate osteoclast formation. Brazilian Journal of Medical and Biological Research. 2014;47(6):461–469. doi: 10.1590/1414-43120132966.

Yanming B. I., Van De Motter R. R., Ragab A. A et al. Titanium particles stimulate bone resorption by inducing differentiation of murine osteoclasts. The Journal of Bone & Joint Surgery. 2001;83(4):501–508.

Zofkova I., Davis M., Blahos J. Trace elements have beneficial, as well as detrimental effects on bone homeostasis. Physiological Research. 2017;66(3):391 – 402.